Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for InvestorsZacks Investment Research · 2 days ago
PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AIGlobeNewsWire · 5 days ago
Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for InvestorsZacks Investment Research · Oct 14, 2026
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewsWire · Oct 14, 2026
PacBio Teams With TychoBio to Advance AI-Driven RNA TherapeuticsZacks Investment Research · Oct 13, 2026
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down – Here’s WhyDefense World · Oct 12, 2026Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 3, 2026 | -$0.13 | -$0.14 | Miss |
| May 7, 2026 | -$0.17 | -$0.03 | Beat |
| Feb 12, 2026 | -$0.19 | -$0.12 | Beat |
| Nov 5, 2025 | -$0.16 | -$0.12 | Beat |
| Aug 7, 2025 | -$0.18 | -$0.13 | Beat |
| May 8, 2025 | -$0.19 | -$1.44 | Miss |